Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
Abstract Deficiency of adenosine deaminase (ADA, EC3.5.4.4), a housekeeping enzyme intrinsic to the purine salvage pathway, leads to severe combined immunodeficiency (SCID) both in humans and mice. Lack of ADA results in the intracellular accumulation of toxic metabolites which have effects on T cel...
Enregistré dans:
Auteurs principaux: | Federico A. Moretti, Giuliana Giardino, Teresa C. H. Attenborough, Athina Soragia Gkazi, Ben K. Margetts, Giancarlo la Marca, Lynette Fairbanks, Tessa Crompton, H. Bobby Gaspar |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f65c7cd9d5074750a94e03ee0d0444ee |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID
par: Claire Booth, et autres
Publié: (2009) - Ada user journal
-
News from ADA congress 2007
par: Editorial team Diabetes Mellitus
Publié: (2007) -
Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models
par: Miao Miao, et autres
Publié: (2021) -
Biografías: Charles Babbage, Augusta Ada Byron
par: José Beltrán, et autres
Publié: (2012)